telemedicine

11 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Healthcare Cybersecurity Market Set to Triple to $97.8B by 2031

Healthcare cybersecurity market projected to grow from $35.78B in 2025 to $97.79B by 2031, with cloud security expanding fastest.
IBMPANWAVGOCSCOFTNT+2regulatory compliancecloud security
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Sleep Apnea Device Market Poised for 7% Annual Growth Through 2034

Global sleep apnea devices market expected to grow 7.05% annually through 2034, driven by rising prevalence and technological advances in CPAP and BiPAP devices.
RMDPHGmarket growthtelemedicine
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Pandemic Winners Turn Bargains: PayPal Opportunity vs. Teladoc Trap

Pandemic darlings PayPal and Teladoc both fell 80%+ over five years, but diverge sharply: PayPal offers generational opportunity; Teladoc represents a value trap.
PYPLTDOCfintechtelemedicine
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

IoT Healthcare Market to Double to $483.7B by 2031 as Remote Monitoring Surges

IoT healthcare market projected to reach $483.72 billion by 2031, growing at 18.46% CAGR from $207.4 billion in 2026, driven by remote monitoring and connected devices.
MSFTMDTSAPIBMCSCO+4remote patient monitoringtelemedicine
BenzingaBenzinga··Globe Newswire

LifeMD Declares Quarterly Dividend on Preferred Stock Series A

LifeMD announces $0.5546875 quarterly dividend per share on Series A Cumulative Perpetual Preferred Stock, payable April 15, 2026.
LFMDLFMDPdividendtelemedicine
GlobeNewswire Inc.GlobeNewswire Inc.··Mangoceuticals, Inc.

Mangoceuticals Sues Clarity Ventures for $73M Over Failed Platform Delivery

Mangoceuticals sues former vendor Clarity Ventures for $73M over failed ERP platform delivery. Company developed proprietary telehealth solution independently.
MGRXtelemedicinelawsuit
The Motley FoolThe Motley Fool··Geoffrey Seiler

Hims & Hers Surges 40% on Novo Nordisk Deal, But Valuation Concerns Linger

Hims & Hers surges 40% after Novo Nordisk partnership resolves litigation, enabling authorized distribution of Wegovy and Ozempic. Stock trades under 20x forward P/E.
NVOHIMSGLP-1 drugstelemedicine
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Respiratory Testing Market Set to Surge 56% by 2032 as Diagnostics Innovation Accelerates

Global respiratory testing market projected to reach $9.32B by 2032, growing 6.50% annually from $5.99B in 2025, driven by molecular diagnostics and telemedicine innovations.
MDTABTRHHBYTMOPHG+3strategic partnershipssupply chain resilience
The Motley FoolThe Motley Fool··Rich Smith

Hims & Hers Faces Growth Deceleration as GLP-1 Market Dynamics Shift

Hims & Hers stock plunged 70% as GLP-1 market competition intensifies and growth slows. Despite challenges, company projects $2.8B 2026 revenue from diversified services.
LLYNVOHIMSearnings reportGLP-1 drugs
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Teladoc Faces Structural Challenges as Telemedicine Market Matures

Teladoc's stock plummeted 98% as telemedicine demand normalized post-pandemic. The company faces structural challenges, slower growth, profitability issues, and intensifying competition from larger healthcare providers.
AMZNTDOCstock declinecompetition
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Talkspace Posts 22% Revenue Growth in 2025 on Strong Payor Segment Gains

Talkspace reported 22% revenue growth in 2025, reaching $228.9M, driven by strong enterprise payor gains despite consumer-direct declines. Turned profitable with $7.8M net income.
TALKTALKWprofitabilityrevenue growth